Insider Shareholders with Direct Ownership of Greenwich Life Sciences, Inc. (GLSI)
This section provides a comprehensive overview of the insiders with direct ownership of Greenwich Life Sciences, Inc. (GLSI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Greenwich LifeSciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Snehal Patel
CEO and CFO |
749,830 | 0 | 5,536,102 $68 Million | 60 |
Sep 26, 2024
Added 0.03%
|
|
David Mc Williams
Director |
173,322 | 0 | 620,301 $7.62 Million | 3 |
Dec 14, 2021
Added 0.03%
|
|
Kenneth Hallock
Director |
300 | 0 | 397,304 $4.88 Million | 1 |
Jan 21, 2022
Added 0.08%
|
|
Eric Rothe
Director |
2,000 | 0 | 313,226 $3.85 Million | 1 |
Nov 20, 2020
Added 0.63%
|
|
Jaye Thompson
VP Clinical Reg Affairs |
11,150 | 0 | 264,148 $3.24 Million | 21 |
Nov 21, 2024
Added 0.38%
|
|
Frank Joseph Daugherty
Chief Medical Officer |
4,111 | 0 | 90,121 $1.11 Million | 4 |
Apr 25, 2022
Added 1.1%
|
|
Pankaj Amrit Patel
> 10% Shareholder |
0 | 561,798 | 0 $0 | 1 |
Nov 10, 2020
Reduced 100.0%
|